Zivo Bioscience Inc ZIVO

$6.25 +0.10 (1.63%)

Valuation

Market cap
26,344,000
Revenue TTM
$120,000
Net income TTM
$-9,890,000
PE ratio
0.00
Forward PE
—
Profit margin
-8,241.67%
Debt to equity
0.00

Trading

Volume
100
Avg volume
1,248
Day's range
$6.25 – $6.25
Shares out
4,215,000
Stochastic %K
78%
Beta
0.38
Analysts
Strong Buy
Price target
$12.00

Price

Company profile

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and com...

Show more

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Industry
Biotechnology
Sector
Healthcare
Phone
248 452 9866
Website
https://www.zivobioscience.com
Address
2125 Butterfield Drive, Suite 100, Troy, United States

Latest news

No headlines yet.